Trials / Unknown
UnknownNCT01402154
EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients
The Pre-treatment Detection of Circulating, Functional, Prostate Cells Among Adenocarcinoma Patients: an Evaluation of the EPISPOT Technique
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 361 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | EPISPOT detection of the number of circulating cells | EPISPOT detection of the number of circulating, functional, prostate cells per unit blood |
| BIOLOGICAL | CellSearch detection of the number of circulating, functional, prostate cells | CellSearch detection of the number of circulating, functional, prostate cells per unit blood |
Timeline
- Start date
- 2012-01-03
- Primary completion
- 2014-12-08
- Completion
- 2021-12-01
- First posted
- 2011-07-26
- Last updated
- 2021-08-05
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01402154. Inclusion in this directory is not an endorsement.